Jonathan E. Golub

Jonathan E. Golub

Auto-generated profile, based on publicly available information

Jonathan E. Golub

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
KDKelly E Dooley
Kelly E Dooley
TTTania Tang
Tania Tang
JGJonathan E. Golub
Jonathan E. Golub
SDSusan E. Dorman
Susan E. Dorman
WCWendy Cronin
Wendy Cronin
Diabetes mellitus (DM) is an emerging chronic health condition of developed and developing countries. We conducted a retrospective cohort study of patients with active, culture-confirmed tuberculosis (TB) in Maryland to determine the impact of DM on TB treatment outcomes. Of 297 TB patients, 42 (14%) had DM. Patients with diabetes had 2.0 times higher odds of death than patients without diabetes (95% confidence interval [CI] 0.74–5.2, P = 0.18). Adjusting for human immunodeficiency virus (HIV), age, weight, and foreign birth, the odds of death were 6.5 times higher in patients with diabetes than patients without diabetes (95% CI 1.1–38.0, P = 0.039). In pulmonary TB patients, time to sputum culture conversion was longer in patients with diabetes than patients without diabetes (median 49 versus 39 days, P = 0.09). Two-month culture conversion proportions were similar (70% and 69%). Treatment failure occurred in 4.1% of patients without diabetes and 6.7% of patients with diabetes (P = 0.51). In conclusion, DM was a risk factor for death in Maryland TB patients. There was a trend toward increased time to culture conversion; two-month culture conversion proportions, however, were similar.

13 March 2009 in AIDS
Verified
Journal Article
Closed access
JGJonathan E Golub
Jonathan E Golub
PPPaul Pronyk
Paul Pronyk
LMLerato Mohapi
Lerato Mohapi
NTNkeko Thsabangu
Nkeko Thsabangu
MMMosa Moshabela
Mosa Moshabela
NMNeil A Martinson
Neil A Martinson
Background: The World Health Organization recommends isoniazid preventive therapy (IPT) for preventing tuberculosis in HIV-infected adults, although few countries have instituted this policy. Both IPT and highly active antiretroviral therapy (HAART) used separately result in reductions in tuberculosis risk. There is less information on the combined effect of IPT and HAART. We assessed the effect of IPT, HAART or both IPT and HAART on tuberculosis incidence in HIV-infected adults in South Africa. Methods: Two clinical cohorts of HIV-infected patients were studied. Primary exposures were receipt of IPT and/or HAART and the primary outcome was incident tuberculosis. Crude incident rates and incident rate ratios were calculated and Cox proportional hazards models investigated associations with tuberculosis risk. Results: Among 2778 HIV-infected patients followed for 4287 person-years, 267 incident tuberculosis cases were diagnosed [incidence rate ratio (IRR) = 6.2/100 person-years; 95% CI 5.5–7.0]. For person-time without IPT or HAART, the IRR was 7.1/100 person-years (95% CI 6.2–8.2); for person-time receiving HAART but without IPT, the IRR was 4.6/100 person-years (95% CI 3.4–6.2); for person-time after IPT but prior to HAART, the IRR was 5.2/100 person-years (95% CI 3.4–7.8); during follow-up in patients treated with HAART after receiving IPT the IRR was 1.1/100 person-years (95% CI 0.02–7.6). Compared to treatment-naive patients, HAART-only patients had a 64% decreased hazard for tuberculosis [adjusted hazard ratio (aHR) = 0.36; 95% CI 0.25–0.51], and patients receiving HAART after IPT had a 89% reduced hazard (aHR = 0.11; 95% CI 0.02–0.78). Conclusion: Tuberculosis risk is significantly reduced by IPT in HAART-treated adults in a high-incidence operational setting in South Africa. IPT is an inexpensive and cost-effective strategy and our data strengthen calls for the implementation of IPT in conjunction with the roll-out of HAART.

1 November 2005
Verified
Journal Article
Closed access
JGJ E Golub
J E Golub
CMC I Mohan
C I Mohan
GCG W Comstock
G W Comstock
RCR E Chaisson
R E Chaisson

15 May 2012 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
ASAdrienne E Shapiro
Adrienne E Shapiro
EVEbrahim Variava
Ebrahim Variava
MRModiehi H. Rakgokong
Modiehi H. Rakgokong
NMNeshen Moodley
Neshen Moodley
BLBinnu Luke
Binnu Luke
NMNeil A. Martinson
Neil A. Martinson
Rationale: South Africa has a high prevalence of tuberculosis (TB) and HIV-coinfected adults in whom TB is often diagnosed late in the course of disease. Objectives: Improved case-finding approaches for TB and HIV are needed to reduce mortality and prevent transmission. Methods: We identified newly diagnosed index TB cases in a rural district and enrolled their households in a TB-HIV contact-tracing study. A group of randomly selected control households were enrolled to determine community prevalence of undetected TB and HIV. Field teams screened participants for TB symptoms, collected sputum specimens for smear microscopy and culture, provided HIV counseling and testing, and collected blood for CD4 testing. Participants were referred to public clinics for TB treatment and antiretroviral therapy. Measurements and Main Results: We evaluated 2,843 household contacts of 727 index patients with TB and 983 randomly selected control household members. The prevalence of TB in household contacts was 6,075 per 100,000 (95% confidence interval, 5,789–6,360 per 100,000), whereas the prevalence detected in randomly selected households was 407 per 100,000 (95% confidence interval, 0–912 per 100,000; prevalence difference, 5,668 per 100,000; P < 0.001). TB detected among contacts was less likely to be smear-positive than in the index patients (6% vs. 22%; P < 0.001). Most contacts with culture-confirmed TB were asymptomatic. At least one case of undiagnosed TB was found in 141 (19%) of 727 contact versus 4 (1%) of 312 control households. HIV testing was positive in 166 (11%) of 1,568 contacts tested versus 76 (14%) of 521 control participants tested (odds ratio, 1.48; P = 0.02). Conclusions: Active case finding in TB contact households should be considered to improve TB and HIV case detection in high-prevalence settings, but sensitive diagnostic tools are necessary.

1 January 2006
Verified
Journal Article
Closed access
JGJ E Golub
J E Golub
SBS Bur
S Bur
WCW A Cronin
W A Cronin
SGS Gange
S Gange
NBN Baruch
N Baruch
RCR E Chaisson
R E Chaisson

1 October 2013 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
BDBetina Durovni
Betina Durovni
VSValeria Saraceni
Valeria Saraceni
LMLawrence H Moulton
Lawrence H Moulton
APAntonio G Pacheco
Antonio G Pacheco
SCSolange C Cavalcante
Solange C Cavalcante
JGJonathan E Golub
Jonathan E Golub